Meeting Material for the Briefing on the Second Quater FY2018 Financial Results
Consolidated Financial Results for the Second Quarter of Fiscal Year 2018
Seikagaku will announce the financial results for the Second Quarter of the Fiscal Year ending March 31, 2019 at 16:00 on November 7, 2018.
Seikagaku and Kaken Announce the Launch of HERNICORE 1.25 Units for Intradiscal Injection in Japan, Indicated for Treatment of Lumbar Disc Herniation
Consolidated Financial Results for the First Quarter of Fiscal 2018